Purchase Order 75N93023P01269
Award Date 9/14/23
Potential Completion Date 12/31/23
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company, doing business as BD, has been awarded a $21,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Whole Transcriptome Analysis amplification reagent kits. The reagent kits will support NIAID's research efforts under the description provided in the original solicitation. Performance will take place in Franklin Lakes, New Jersey over a four month period concluding at the end of...
- Becton, Dickinson and Company, doing business as BD, has been awarded a $20,504.50 firm fixed price purchase order contract by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide BD Biosciences reagents. The place of performance will be BD's facility in Franklin Lakes, New Jersey. The contract period of performance spans from September 14, 2023 through December 29, 2023. No major subcontractors or set aside...
- Becton, Dickinson and Company, doing business as BD, has been awarded a purchase order contract valued at approximately $13,924.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the terms of the contract, BD will provide BD Antibodies (AMBIS #2187100) to support NIH/NIAID's research efforts related to allergies and infectious diseases. Place of performance will be BD's facilities in Franklin Lakes, New Jersey, with work expected to be...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,072.00 firm fixed price purchase order contract to Becton, Dickinson And Company (BD) for BD reagents to support vaccine research. The contract does not have a set-aside designation and is scheduled for completion on February 24, 2023. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center. Valued at eleven thousand six hundred seventy-one dollars and sixty cents ($11,671.60), this award is for the RHAPSODY Targeted mRNA ABSEQ Kit. Delivery is required by February 23, 2024. As a manufacturer and supplier of medical devices, instruments, reagents, and related products, BD will provide the requested...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- This is a $6,532 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is not set aside for any particular business category. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, including through flow cytometry, cell imaging, and genomics...
- This is a $68,497.20 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson And Company (BD) for the delivery of biological reagents. The contract has a period of performance through July 31, 2025. BD is a global medical technology company that has received numerous federal contract and subcontract awards to provide specialized equipment, consumables, and services in support of biomedical...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for COVID-19 research. The $132,747.71 firm-fixed-price purchase order is for BD reagents to support mission-critical COVID-19 pre- and post-vaccine studies. The contract has no set-aside designation. BD is a global medical technology manufacturer that provides a wide range of products and...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order valued at fifteen thousand dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. This award is for pre-contract inspection services to support the BD FACSymphony A5 cell analyzer, to be performed in Bethesda, Maryland. No set-aside designation was used for this procurement. BD Biosciences, a division of BD, will provide the required inspection services...